Doxapram increases corticotropin-releasing factor immunoreactivity and mRNA expression in the rat central nucleus of the amygdala
- 30 November 2005
- Vol. 26 (11), 2246-2251
- https://doi.org/10.1016/j.peptides.2005.03.036
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The Role of the Central Nucleus of the Amygdala in Mediating Fear and Anxiety in the PrimateJournal of Neuroscience, 2004
- CRH Signalling in the Bed Nucleus of the Stria Terminalis is Involved in Stress-Induced Cardiac Vagal Activation in Conscious RatsNeuropsychopharmacology, 2001
- Emotion Circuits in the BrainAnnual Review of Neuroscience, 2000
- Norepinephrine release in the amygdala after systemic injection of epinephrine or escapable footshock: Contribution of the nucleus of the solitary tract.Behavioral Neuroscience, 1998
- Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasing factor gene expression in conscious ratsEndocrinology, 1994
- The Role of the Amygdala in Fear and AnxietyAnnual Review of Neuroscience, 1992
- Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complexBrain Research, 1986
- Circadian rhythm of corticotropin releasing factor-like immunoreactivity in rat hypothalamusPeptides, 1984
- Organization of Ovine Corticotropin-Releasing Factor Immunoreactive Cells and Fibers in the Rat Brain: An Immunohistochemical StudyNeuroendocrinology, 1983
- Modification of Cardiopressor and Respirogenic Effects of Doxapram by PropranololClinical Toxicology, 1978